Development of Genomic and Immunological Approaches to Pathogen Detection – Sole Source to Silver Lake Research

The DHS Directorate of Science and Technology, Chemical and Biological Defense Division (CBD) proposes to enter into a sole source award to Silver Lake Research Corporation (SLRC), 911 South Primrose Avenue Monrovia, CA for purposes of continuing and completing the research and development required to generate threat agent specific monoclonal antibodies for which current gold standards methods are not able to generate a highly specific product to support the development of rapid detection assays.

Source: www.fbo.gov

Specialty Vaccine Company PaxVax Announces Positive Efficacy Results for Phase 3 Cholera Challenge Study

PaxVax Inc., a specialty vaccine company with a commercial focus on travel and biodefense and a social mission to ensure global access to its vaccines, today announced positive efficacy results from the 90-day challenge studies of its single-dose oral cholera vaccine candidate, PXVX0200, which utilizes the same attenuated vaccine strain previously approved and marketed in several countries under the …

Source: finance.yahoo.com